Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Chinese Medicine
Published in: Chinese Medicine 1/2018

Open Access 01-12-2018 | Review

Anticancer drug discovery from Chinese medicinal herbs

Authors: Mu-Yang Huang, Le-Le Zhang, Jian Ding, Jin-Jian Lu

Published in: Chinese Medicine | Issue 1/2018

Login to get access

Abstract

Cancer is still presenting a serious threat to human health worldwide. The understanding of the complex biology of cancer and the development of oncotherapy have led to increasing treatment approaches such as targeted therapy and immunotherapy. Chinese medicinal herbs have attracted considerable attention due to their potential anticancer effects. Some natural products or formulae from Chinese medicinal herbs with directly or indirectly anticancer effects have been reported. In this article, we summarized the current progression on development of anticancer drugs from Chinese medicinal herbs, toward providing ideas for further development and application of Chinese medicinal herbs in cancer therapy.
Literature
1.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMed
2.
3.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32.CrossRefPubMed
4.
Arruebo M, Vilaboa N, Saez-Gutierrez B, Lambea J, Tres A, Valladares M, et al. Assessment of the evolution of cancer treatment therapies. Cancers. 2011;3:3279–330.CrossRefPubMedPubMedCentral
5.
6.
Chae YK, Pan AP, Davis AA, Patel SP, Carneiro BA, Kurzrock R, et al. Path toward precision oncology: review of targeted therapy studies and tools to aid in defining “Actionability” of a molecular lesion and patient management support. Mol Cancer Ther. 2017;16:2645–55.CrossRefPubMed
7.
8.
Judson PL, Abdallah R, Xiong Y, Ebbert J, Lancaster JM. Complementary and alternative medicine use in individuals presenting for care at a comprehensive cancer center. Integr Cancer Ther. 2017;16:96–103.CrossRefPubMed
9.
10.
Liu J, Wang S, Zhang Y, Fan HT, Lin HS. Traditional Chinese medicine and cancer: history, present situation, and development. Thorac Cancer. 2015;6:561–9.CrossRefPubMedPubMedCentral
11.
Hsiao WL, Liu L. The role of traditional Chinese herbal medicines in cancer therapy—from TCM theory to mechanistic insights. Planta Med. 2010;76:1118–31.CrossRefPubMed
12.
Zhang Y, Liang Y, He C. Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine. Chin Med. 2017;12:20.CrossRefPubMedPubMedCentral
13.
Gill H, Yim R, Lee HKK, Mak V, Lin SY, Kho B, et al. Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: a 15-year prospective study. Cancer. 2018;124:2316–26.CrossRefPubMed
14.
Rockwell S, Grove TA, Liu Y, Cheng YC, Higgins SA, Booth CJ. Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy. Int J Radiat Biol. 2013;89:16–25.CrossRefPubMed
15.
Katz L, Baltz RH. Natural product discovery: past, present, and future. J Ind Microbiol Biotechnol. 2016;43:155–76.CrossRefPubMed
16.
17.
Swinney D. Phenotypic vs. target-based drug discovery for first-in-class medicines. Clin Pharmacol Ther. 2013;93:299–301.CrossRefPubMed
18.
Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265–79.CrossRefPubMed
19.
20.
Johnson RK. Screening methods in antineoplastic drug discovery. J Natl Cancer Inst. 1990;82:1082–3.CrossRefPubMed
21.
Rowinsky EK, Calvo E. Novel agents that target tublin and related elements. Semin Oncol. 2006;33:421–35.CrossRefPubMed
22.
Newlands E, Stevens M, Wedge S, Wheelhouse R, Brock C. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev. 1997;23:35–61.CrossRefPubMed
23.
Lee DH, Szczepanski MJ, Lee YJ. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. J Cell Biochem. 2009;106:1113–22.CrossRefPubMed
24.
Li L, Lin J, Sun G, Wei L, Shen A, Zhang M, et al. Oleanolic acid inhibits colorectal cancer angiogenesis in vivo and in vitro via suppression of STAT3 and Hedgehog pathways. Mol Med Rep. 2016;13:5276–82.CrossRefPubMed
25.
26.
27.
Pei Z, Fu W, Wang G. A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signaling. Biochem Biophys Res Commun. 2017;493:455–60.CrossRefPubMed
28.
Moffat JG, Rudolph J, Bailey D. Phenotypic screening in cancer drug discovery—past, present and future. Nat Rev Drug Discov. 2014;13:588.CrossRefPubMed
29.
Huang M, Lu JJ, Huang MQ, Bao JL, Chen XP, Wang YT. Terpenoids: natural products for cancer therapy. Expert Opin Investig Drugs. 2012;21:1801–18.CrossRefPubMed
30.
Lu JJ, Bao JL, Wu GS, Xu WS, Huang MQ, Chen XP, et al. Quinones derived from plant secondary metabolites as anti-cancer agents. Anticancer Agents Med Chem. 2013;13:456–63.PubMed
31.
Lu JJ, Bao JL, Chen XP, Huang M, Wang YT. Alkaloids isolated from natural herbs as the anticancer agents. Evid Based Complement Altern Med. 2012;2012:485042.
32.
Xu XH, Li T, Fong CM, Chen X, Chen XJ, Wang YT, et al. Saponins from Chinese medicines as anticancer agents. Molecules. 2016;21:1326.CrossRefPubMedCentral
33.
Venkata Sairam K, Gurupadayya BM, Chandan RS, Nagesha DK, Vishwanathan B. A review on chemical profile of coumarins and their therapeutic role in the treatment of cancer. Curr Drug Deliv. 2016;13:186–201.CrossRefPubMed
34.
Yao H, Liu J, Xu S, Zhu Z, Xu J. The structural modification of natural products for novel drug discovery. Expert Opin Drug Discov. 2017;12:121–40.CrossRefPubMed
35.
Li QY, Zu YG, Shi RZ, Yao LP. Review camptothecin: current perspectives. Curr Med Chem. 2006;13:2021–39.CrossRefPubMed
36.
Sriram D, Yogeeswari P, Thirumurugan R, Ratan Bal T. Camptothecin and its analogues: a review on their chemotherapeutic potential. Nat Prod Res. 2005;19:393–412.CrossRefPubMed
37.
Ding C, Tian Q, Li J, Jiao M, Song S, Wang Y, et al. Structural modification of natural product tanshinone I leading to discovery of novel nitrogen-enriched derivatives with enhanced anticancer profile and improved drug-like properties. J Med Chem. 2018;61:760–76.CrossRefPubMed
38.
Lu P, Zhang FC, Qian SW, Li X, Cui ZM, Dang YJ, et al. Artemisinin derivatives prevent obesity by inducing browning of WAT and enhancing BAT function. Cell Res. 2016;26:1169–72.CrossRefPubMedPubMedCentral
39.
40.
Ma N, Wang Y, Zhao BX, Ye WC, Jiang S. The application of click chemistry in the synthesis of agents with anticancer activity. Drug Des Dev Ther. 2015;9:1585–99.
41.
Wang R, Li L, Zhang S, Li Y, Wang X, Miao Q, et al. A novel enediyne-integrated antibody-drug conjugate shows promising antitumor efficacy against CD30(+) lymphomas. Mol Oncol. 2018;12:339–55.CrossRefPubMedPubMedCentral
42.
Xu W, Xing FJ, Dong K, You C, Yan Y, Zhang L, et al. Application of traditional Chinese medicine preparation in targeting drug delivery system. Drug Deliv. 2015;22:258–65.CrossRefPubMed
43.
Li W, Yin H, Bardelang D, Xiao J, Zheng Y, Wang R. Supramolecular formulation of nitidine chloride can alleviate its hepatotoxicity and improve its anticancer activity. Food Chem Toxicol. 2017;109:923–9.CrossRefPubMed
44.
Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends. 2015;9:16–34.CrossRefPubMed
45.
Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, et al. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 2010;4:297–307.PubMed
46.
Cheng YC, Tsai MY, Chen CJ, Hung YC. Combination therapy of traditional Chinese medicine and Western medicine to treat refractory polymyositis: a case report. J Altern Complement Med. 2015;21:304–6.CrossRefPubMed
47.
Chen S, Flower A, Ritchie A, Liu J, Molassiotis A, Yu H, et al. Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: a systematic review. Lung Cancer. 2010;68:137–45.CrossRefPubMed
48.
Gao Y, Chu S, Shao Q, Zhang M, Xia C, Wang Y, et al. Antioxidant activities of ginsenoside Rg1 against cisplatin-induced hepatic injury through Nrf2 signaling pathway in mice. Free Radic Res. 2017;51:1–13.CrossRefPubMed
49.
Yu J, Wang C, Kong Q, Wu X, Lu JJ, Chen X. Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products. Phytomedicine. 2018;40:125–39.CrossRefPubMed
50.
Sahu BD, Kumar JM, Kuncha M, Borkar RM, Srinivas R, Sistla R. Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice. Life Sci. 2016;144:8–18.CrossRefPubMed
51.
Jia Y, Zuo D, Li Z, Liu H, Dai Z, Cai J, et al. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway. Chem Pharm Bull. 2014;62:45–53.CrossRef
52.
Pirker R, Pereira JR, Szczesna A, Von Pawel J, Krzakowski M, Ramlau R, et al. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet. 2009;373:1525–31.CrossRefPubMed
53.
Li T, Chen X, Chen X, Ma DL, Leung CH, Lu JJ. Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells. Sci Rep. 2016;6:37997.CrossRefPubMedPubMedCentral
54.
Li T, Chen X, Dai XY, Wei B, Weng QJ, Chen X, et al. Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor. Toxicol Appl Pharmacol. 2017;330:65–73.CrossRefPubMed
55.
Zhu H, Ding WJ, Wu R, Weng QJ, Lou JS, Jin RJ, et al. Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol. Cancer Invest. 2010;28:23–32.CrossRefPubMed
56.
Bhaw-Luximon A, Jhurry D. Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives. Cancer Chemother Pharmacol. 2017;79:451–66.CrossRefPubMed
57.
Guan Z, Lan H, Chen X, Jiang X, Li Z, Yu X, et al. Synergistic effects and mechanism of Danshen injection in combination with chemotherapy and antiangiogenic therapy for colon cancer. Int J Clin Exp Med. 2017;10:6437–44.
58.
Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13:714–26.CrossRefPubMed
59.
60.
61.
Li Y, Wang Y, Niu K, Chen X, Xia L, Lu D, et al. Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation. Oncotarget. 2016;7:70535.PubMedPubMedCentral
62.
Chen Q, Qin R, Fang Y, Li H. Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93/PTEN/Akt signaling pathway. Cell Physiol Biochem. 2015;36:956–65.CrossRefPubMed
63.
Qi YB, Wu JH, Liu BY, Zhang DS. Effects of Xue Fu Zhu Yu decoction on immune function of tumor-bearing mice. Modern Prev Med. 2005;5:446–8.
64.
Lu XF. Experimental study on the effects of chemotherapy combined with Xuefu Zhuyu decoction polysaccharide on transplanted tumor in rats. Mod J Integr Tradit Chin West Med. 2008;16:2446–7.
65.
Zhang K, Zhang J, Wang X, Wang L, Pugliese M, Passantino A, et al. Cardioprotection of Sheng Mai Yin a classic formula on adriamycin induced myocardial injury in Wistar rats. Phytomedicine. 2018;38:1–11.CrossRefPubMed
66.
Liu SH, Cheng YC. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol. 2012;140:614–23.CrossRefPubMed
67.
Lam W, Bussom S, Guan F, Jiang Z, Zhang W, Gullen EA, et al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med. 2010;2:45ra59.CrossRefPubMed
68.
Lam W, Jiang Z, Guan F, Huang X, Hu R, Wang J, et al. PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment. Sci Rep. 2015;5:9384.CrossRefPubMedPubMedCentral
69.
Gao D, Wang B, Huo Z, He Y, Polachi N, Lei Z, et al. Analysis of chemical constituents in an herbal formula Jitong Ning Tablet. J Pharm Biomed Anal. 2017;140:301–12.CrossRefPubMed
70.
Li X, Sun H, Zhang A, Liu Z, Zou D, Song Y, et al. High-throughput LC–MS method for the rapid characterization of multiple chemical constituents and metabolites of Da-Bu-Yin-Wan. J Sep Sci. 2017;40:4102–12.CrossRefPubMed
71.
Tilton R, Paiva AA, Guan JQ, Marathe R, Jiang Z, van Eyndhoven W, et al. A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906. Chin Med. 2010;5:30.CrossRefPubMedPubMedCentral
72.
Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA. 2008;105:4826–31.CrossRefPubMedPubMedCentral
73.
Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. Mol BioSyst. 2014;10:1014–22.CrossRefPubMed
74.
Chen M, Yang F, Yang X, Lai X, Gao Y. Systematic understanding of mechanisms of a Chinese herbal formula in treatment of metabolic syndrome by an integrated pharmacology approach. Int J Mol Sci. 2016;17:2114.CrossRefPubMedCentral
75.
Li SP, Zhao J, Yang B. Strategies for quality control of Chinese medicines. J Pharm Biomed Anal. 2011;55:802–9.CrossRefPubMed
76.
Liang Y, Xie P, Chau F. Chromatographic fingerprinting and related chemometric techniques for quality control of traditional Chinese medicines. J Sep Sci. 2010;33:410–21.CrossRefPubMed
77.
Hall AB, Tolonen AC, Xavier RJ. Human genetic variation and the gut microbiome in disease. Nat Rev Genet. 2017;18:690–9.CrossRefPubMed
78.
Li J, Sung CY, Lee N, Ni Y, Pihlajamaki J, Panagiotou G, et al. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci USA. 2016;113:E1306–15.CrossRefPubMedPubMedCentral
79.
Peuker K, Muff S, Wang J, Kunzel S, Bosse E, Zeissig Y, et al. Epithelial calcineurin controls microbiota-dependent intestinal tumor development. Nat Med. 2016;22:506–15.CrossRefPubMedPubMedCentral
80.
Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079–84.CrossRefPubMedPubMedCentral
81.
Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084–9.CrossRefPubMedPubMedCentral
82.
Metadata
Title
Anticancer drug discovery from Chinese medicinal herbs
Authors
Mu-Yang Huang
Le-Le Zhang
Jian Ding
Jin-Jian Lu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Chinese Medicine / Issue 1/2018
Electronic ISSN: 1749-8546
DOI
https://doi.org/10.1186/s13020-018-0192-y

Other articles of this Issue 1/2018

Chinese Medicine 1/2018 Go to the issue

Research

Development of models for classification of action between heat-clearing herbs and blood-activating stasis-resolving herbs based on theory of traditional Chinese medicine

Review

Pharmacokinetics of Chinese medicines: strategies and perspectives

Research

Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome

Research

Complete chloroplast genome of the medicinal plant Amomum compactum: gene organization, comparative analysis, and phylogenetic relationships within Zingiberales

Research

Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease

Research

Metabonomic study of the protective effect of Fukeqianjin formula on multi-pathogen induced pelvic inflammatory disease in rats